Experts: PASTEUR, VALID Could Help Spur Bacterial Diagnostics For AMR

By Lia DeGroot / September 22, 2022 at 11:15 AM
Diagnostic tests are essential to combating antimicrobial resistance (AMR), but developers face myriad challenges getting their tests through FDA, and the ones that do make it to market have to grapple with reimbursement issues, a panel of former FDA officials, academics and industry experts said during a Duke-Margolis webinar last week. The experts, who called for increasing funding for bacterial diagnostics, noted that two bills being considered by Congress -- the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.